Share This Link

This question focuses on identifying suicide risk factors in a client experiencing severe depressive symptoms after major life stressors. The client has experienced the loss of a long-term relationship and employment, both of which are significant psychosocial triggers for depression and suicidal thinking. Progressive withdrawal, hopelessness, flat affect, and verbal expressions about not wanting to live are major warning signs requiring immediate intervention. Early recognition of suicidal ideation is critical because emotional distress can rapidly progress to self-harm or suicide attempts without timely support and safety measures.

Rationale for correct choices:

• Suicidal ideation: The client demonstrates multiple classic indicators of suicidal ideation, including hopelessness, social withdrawal, worthlessness, and the statement, “I wish I weren’t here.” Verbalizing a desire not to live is a significant warning sign that must always be taken seriously. The initiation of one-on-one observation further supports concern for self-harm risk and indicates the need for close monitoring and suicide precautions. Clients experiencing major losses are particularly vulnerable to suicidal thoughts during depressive episodes.

• Statements of hopelessness and wishing not to be alive: Hopelessness is one of the strongest psychological predictors of suicide risk because it reflects a belief that circumstances will not improve. The client’s statements reveal despair, emotional exhaustion, and passive death wishes, all of which are concerning for suicidal ideation. Combined with tearfulness, isolation, and feelings of worthlessness, these statements suggest significant emotional instability. Such findings require immediate assessment of suicidal intent, plan, and access to means.

Rationale for incorrect choices:

• Acute stress disorder: Acute stress disorder occurs after exposure to a traumatic event involving actual or threatened death, serious injury, or sexual violence. Symptoms typically include dissociation, intrusive memories, hypervigilance, and avoidance behaviors shortly after the trauma. Although this client is under emotional stress, the presentation is more consistent with depressive symptoms and suicide risk rather than trauma-related stress pathology. No evidence of dissociative or trauma-reexperiencing symptoms is present.

• Borderline personality disorder: This is characterized by chronic interpersonal instability, impulsivity, fear of abandonment, unstable self-image, and recurrent self-destructive behaviors beginning in early adulthood. The scenario does not describe a long-standing maladaptive personality pattern or impulsive relationship instability. Instead, the symptoms appear linked to recent situational losses and depressive reactions.

• Recent increase in appetite and energy level: An increase in appetite and energy level is not documented in this scenario and would not directly support suicide risk in the way hopeless verbalizations do. In some depressed clients, sudden increased energy after severe depression can raise concern for suicide because the individual may gain energy to act on suicidal thoughts. However, this client instead demonstrates lethargy, withdrawal, tearfulness, and hopelessness.

• Participation in group activities with peers: Participation in group activities generally suggests social engagement and willingness to interact with others, which are protective rather than high-risk behaviors. The client in this scenario is withdrawn from family and friends and remains isolated in bed. Social isolation commonly worsens depression and increases suicide risk by reducing emotional support systems. Therefore, active peer participation would not support the identified concern.

This clinical scenario discusses the recognition and management of acute gout in a client with multiple predisposing risk factors. Gout is an inflammatory arthritis caused by deposition of monosodium urate crystals within joints, most commonly affecting the first metatarsophalangeal joint of the great toe. The client presents with classic manifestations including sudden severe toe pain, redness, warmth, and extreme tenderness. Recent initiation of hydrochlorothiazide, chronic kidney disease, obesity, and regular alcohol intake all increase uric acid retention and significantly raise the risk of acute gout attacks.

Rationale for correct choices:

• Gout: The client’s presentation strongly supports acute gouty arthritis. The abrupt onset of severe pain in the right great toe with redness, warmth, and hypersensitivity to even light touch is classic for podagra, the most common form of gout. Hydrochlorothiazide contributes to hyperuricemia by decreasing renal uric acid excretion, while chronic kidney disease further impairs urate clearance. Alcohol intake, obesity, and hypertension are additional major risk factors supporting this diagnosis.

• Recommend a low purine diet: Dietary modification is an important part of gout management because purines are metabolized into uric acid. Foods such as red meat, seafood, and alcohol, especially beer and wine, can precipitate acute attacks by increasing uric acid levels. Teaching the client to reduce purine intake helps decrease crystal deposition and recurrence frequency. Increased hydration is also encouraged to support renal excretion of uric acid.

• Anticipate a prescription for colchicine: Colchicine is commonly prescribed for acute gout flares because it reduces the inflammatory response caused by urate crystal deposition. It works by inhibiting neutrophil activity within the affected joint, thereby decreasing pain, swelling, and inflammation. Early treatment is most effective in shortening attack duration and improving comfort. Colchicine is particularly useful when NSAIDs are not ideal, such as in clients with chronic kidney disease.

• Pain level: Pain level is an important parameter to monitor because acute gout attacks are extremely painful and pain severity reflects the degree of inflammation. Monitoring pain helps evaluate response to medications such as colchicine and guides further treatment decisions. Improvement in pain indicates reduction of crystal-induced joint inflammation. Persistent or worsening pain may suggest ineffective therapy or alternative diagnoses requiring reassessment.

• Uric acid level: Monitoring uric acid levels helps assess long-term control of hyperuricemia and effectiveness of preventive interventions. Elevated serum uric acid contributes to recurrent gout attacks and chronic joint damage if untreated. Although uric acid may occasionally appear normal during an acute flare, trending levels over time is clinically valuable. Monitoring is especially important in clients with kidney disease and diuretic use because both impair uric acid elimination.

Rationale for incorrect choices:

• Refer the client for a foot x-ray: A foot x-ray is not the priority because there is no history of trauma or evidence suggesting fracture. Acute gout is primarily diagnosed clinically based on symptoms and risk factors, particularly involvement of the great toe with intense inflammation. Imaging may be considered later if chronic joint damage is suspected, but it is not the immediate intervention for this presentation. The client’s findings are more consistent with inflammatory crystal arthritis.

• Request a prescription for antibiotics: Antibiotics are used to treat bacterial infections and are not indicated for uncomplicated gout. Although the toe is red and warm, these inflammatory findings result from urate crystal deposition rather than infection. The client has no fever, systemic infection signs, or evidence of septic arthritis. Unnecessary antibiotic use could expose the client to adverse effects without treating the underlying condition.

• Anticipate a prescription for methotrexate: Methotrexate is a disease-modifying antirheumatic drug primarily used for autoimmune disorders such as rheumatoid arthritis and psoriasis. It does not treat acute gout attacks or reduce uric acid crystal inflammation. The client’s symptoms are episodic and localized rather than chronic symmetric inflammatory arthritis. Therefore, methotrexate would not be an appropriate first-line therapy in this scenario.

• Fracture: A fracture usually follows trauma and often presents with deformity, impaired mobility, bruising, or swelling related to injury. The client specifically denies bumping or injuring the toe, making fracture less likely. The hypersensitivity to even a bedsheet touching the toe is highly characteristic of gout rather than bone injury. Additionally, the recent hydrochlorothiazide initiation strongly supports a metabolic cause.

• Shingles: Shingles typically presents with a painful unilateral vesicular rash following a dermatomal distribution caused by reactivation of varicella-zoster virus. The client has no rash, blistering, or neuropathic burning pain pattern associated with shingles. The isolated inflammation of the great toe is inconsistent with viral nerve involvement. Therefore, shingles does not fit the assessment findings.

• Septic arthritis: Septic arthritis is a serious joint infection that usually presents with fever, severe joint pain, swelling, and systemic illness. Although the toe is inflamed, the client does not have fever, chills, or toxic appearance suggestive of infection. The timing after hydrochlorothiazide initiation and classic podagra presentation favor gout instead. Septic arthritis remains important to rule out if symptoms worsen or systemic findings develop.

• Rash: Rash monitoring would be more relevant for conditions such as shingles or allergic reactions, not gout. Gout primarily causes localized inflammatory joint manifestations rather than cutaneous eruptions. The client’s toe redness is due to inflammation beneath the skin rather than a dermatologic rash. Rash monitoring would not best evaluate progression or treatment response.

• CBC: A complete blood count may be useful if infection is suspected, but it is not the primary parameter for monitoring uncomplicated gout management. The priority is assessing symptom relief and uric acid control rather than infection markers. Since the client lacks systemic signs of infection, serial CBC monitoring is less clinically relevant. Pain assessment and uric acid levels provide more direct evaluation of gout progression.

• Temperature: Monitoring temperature is more important when infection or systemic inflammatory response is suspected. The client does not currently exhibit fever or signs of septic arthritis. While temperature may still be assessed routinely, it is not the most specific indicator of gout improvement. Pain reduction and uric acid management are more useful measures of therapeutic response.

This question focuses on identifying manifestations of opioid-induced respiratory depression following IV morphine administration. Morphine is an opioid analgesic that depresses the central nervous system and can suppress the respiratory drive, especially in postoperative clients who are already sedated from anesthesia. Findings such as somnolence, pinpoint pupils, bradypnea, hypotension, and decreased respiratory effort are classic indicators of opioid toxicity. Early recognition is critical because progressive respiratory depression can rapidly lead to hypoxia, respiratory arrest, and cardiovascular collapse.

Rationale for Correct findings:

• Decreased respiratory effort, bilateral crackles: Decreased respiratory effort following morphine administration is a serious sign of opioid-induced respiratory depression. Opioids suppress the medullary respiratory center, leading to slower and shallower breathing that reduces oxygen exchange. Bilateral crackles may indicate retained secretions, atelectasis, or developing pulmonary complications due to hypoventilation. This finding requires immediate nursing intervention, including respiratory assessment, oxygen support, and possible naloxone administration.

• Somnolent: Excessive somnolence is an early neurologic indicator of opioid oversedation and can precede respiratory arrest. A client who becomes increasingly difficult to arouse may not maintain adequate airway protection or respiratory effort. Monitoring the level of consciousness is essential because declining neurologic responsiveness correlates closely with worsening respiratory depression. Immediate reassessment and provider notification are warranted.

• Pinpoint pupils: Pinpoint pupils, or miosis, are a classic manifestation of opioid effects on the central nervous system. In the postoperative setting, this finding strongly suggests excessive opioid activity, particularly when accompanied by sedation and bradypnea. Although miosis alone may not be dangerous, it becomes clinically significant when occurring alongside respiratory depression. This finding helps confirm suspected opioid toxicity and requires prompt evaluation.

• Respiratory rate 10/min: A respiratory rate of 10/min is abnormally low and indicates bradypnea, which is a major concern after opioid administration. Respiratory depression is one of the most dangerous adverse effects of morphine because inadequate ventilation can lead to carbon dioxide retention and hypoxemia. A declining respiratory rate often precedes respiratory arrest if untreated. Immediate assessment and intervention are necessary to prevent deterioration.

• Blood pressure 98/58 mm Hg: Hypotension can occur with morphine because opioids cause peripheral vasodilation and reduce sympathetic nervous system activity. The client’s blood pressure has dropped significantly from baseline, suggesting a clinically important hemodynamic effect. Combined with sedation and respiratory depression, hypotension may indicate worsening opioid toxicity. Reduced perfusion can compromise oxygen delivery to vital organs and requires urgent monitoring and management.

Rationale for incorrect findings:

• S1, S2, no murmur, bradycardia: A heart rate of 58/min represents mild bradycardia, which can occur postoperatively or secondary to opioid administration. While it should continue to be monitored, it is less immediately dangerous than respiratory depression or altered consciousness. The absence of murmurs or abnormal heart sounds suggests no acute structural cardiac complication.

• Temperature 37.4° C (99.4° F): A temperature of 37.4°C is within a mild postoperative range and does not indicate acute infection or severe systemic complication. Slight elevations in temperature can occur after surgery because of inflammation or stress response. Compared with the client’s respiratory and neurologic changes, this finding is not immediately life-threatening. Ongoing monitoring is appropriate, but urgent intervention is not required based on temperature alone.

• Heart rate 58/min: Although slightly below normal, a heart rate of 58/min is not as critical as the client’s low respiratory rate and decreased responsiveness. Mild bradycardia may occur due to opioid effects, vagal stimulation, or postoperative relaxation. Since perfusion is still being maintained and no dysrhythmias are described, it is a secondary concern at this time. Airway and breathing abnormalities take priority over circulation in this scenario.